Improving Sleep and Learning in Rehabilitation After Stroke, Part 2 (INSPIRES-2)
Primary Purpose
Stroke
Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Digital Cognitive Behavioural Therapy for Insomnia
Sponsored by
About this trial
This is an interventional treatment trial for Stroke focused on measuring Sleep, Rehabilitation, Digital, Cognitive Behavioural Therapy for Insomnia, Motor consolidation
Eligibility Criteria
Inclusion Criteria:
- Willing and able to give informed consent for participation in the study
- Aged 18 years or above.
- Clinical diagnosis of stroke affecting the upper limb, with sufficient movement to perform the motor learning task
- Discharged from inpatient care
- Interest in accessing a programme with the aim of improving sleep quality
- Reliable access to the internet
Exclusion Criteria:
- Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis)
- Diagnosed, untreated, sleep disorder (e.g. Sleep Apnea)
- Uncontrolled seizures
- Planned inpatient admission (e.g. for rehabilitation) in the next 4 months that would impact ability to engage with the Sleepio programme
- Engagement in psychological therapy for insomnia in the past 12 months
- Pregnancy
Sites / Locations
- University of OxfordRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Behavioural: Digital cognitive behavioural therapy for insomnia
Treatment as usual
Arm Description
6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online.
Participants will receive treatment as usual.
Outcomes
Primary Outcome Measures
Sleep Condition Indicator
Questionnaire assessing self-reported insomnia symptoms, range 0-32, higher numbers indicate less symptoms of insomnia
Secondary Outcome Measures
Change in motor performance from training to retest
Behavioural motor consolidation assessment, assessed as accuracy (range 0-50, higher numbers indicate better accuracy of motor performance)
Patient Health Questionnaire
Questionnaire assessing symptoms of depression, range 0-20, higher values indicate more depressive symptoms
Fatigue Severity Scale
Questionnaire assessing fatigue, range 9-63, higher score indicates more severe fatigue
Actigraphy
Wearable activity monitor used for assessing sleep disruption (Total Sleep Time, Wake After Sleep Onset, sleep fragmentation)
Full Information
NCT ID
NCT05511285
First Posted
August 16, 2022
Last Updated
December 12, 2022
Sponsor
University of Oxford
Collaborators
Big Health Inc.
1. Study Identification
Unique Protocol Identification Number
NCT05511285
Brief Title
Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
Acronym
INSPIRES-2
Official Title
Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 13, 2022 (Actual)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oxford
Collaborators
Big Health Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will explore whether sleep in stroke survivors is improved with digital cognitive behavioural therapy for insomnia (Sleepio), in comparison to treatment as usual, and will explore whether changes in sleep relate to changes in overnight consolidation of motor learning.
Detailed Description
Stroke is one of the leading causes of adult disability. Rehabilitation of movement after stroke depends on motor learning. Motor learning involves not only improvement during practice but also offline improvement, or consolidation, that occurs after practice. Consolidation of learning depends on good sleep quality. However, sleep is disrupted long-term after stroke and patients with poorer sleep show worse rehabilitation outcomes.
Cognitive behavioural therapy for insomnia (CBT) is the recommended first line treatment for sleep problems. "Sleepio" is a digital CBT programme which is effective across a range of clinical populations. This study aims to test the efficacy of digital CBT for reducing insomnia symptoms after stroke, in comparison with usual care alone. To explore the possibility that sleep interventions might enhance rehabilitation outcomes via their impact on consolidation of motor learning, the study will additionally test for differences in consolidation between groups, and explore whether changes in sleep measures are associated with changes in consolidation.
Participants will be randomised to either receive digital CBT for insomnia (in addition to usual care) or receive treatment as usual alone (2:1 treatment to control ratio). The primary outcome is the score on the 8-item Sleep Condition Indicator, 10 weeks following randomisation. Secondary outcomes include behavioural measures of overnight motor consolidation assessed as the change in motor task performance from training to retest, sleep disruption assessed with actigraphy, and depression and fatigue using the Patient Health Questionnaire (PHQ9) and the Fatigue Severity Scale respectively.
In addition to this, to explore the feasibility of delivering rehabilitation following the sleep improvement programme, an optional 4 weeks of upper limb motor training at home will be offered to all participants (regardless of group allocation) after follow-up. Outcomes of adherence to the training and upper limb function will be assessed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Sleep, Rehabilitation, Digital, Cognitive Behavioural Therapy for Insomnia, Motor consolidation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A randomised controlled trial with two parallel study arms: (1) digital cognitive behavioural therapy for insomnia (experimental condition), and (2) treatment as usual (control condition). Randomisation will be using a 2:1 ratio (experimental:control), within minimisation of between group differences in age, sex, baseline Sleep Condition Indicator score and time since stroke.
Masking
Outcomes Assessor
Masking Description
Randomisation and facilitation of the intervention will be performed by a research assistant, and the person analysing the data will be blinded to group allocations.
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Behavioural: Digital cognitive behavioural therapy for insomnia
Arm Type
Experimental
Arm Description
6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online.
Arm Title
Treatment as usual
Arm Type
No Intervention
Arm Description
Participants will receive treatment as usual.
Intervention Type
Behavioral
Intervention Name(s)
Digital Cognitive Behavioural Therapy for Insomnia
Other Intervention Name(s)
Sleepio
Intervention Description
6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online, in addition to usual care.
Primary Outcome Measure Information:
Title
Sleep Condition Indicator
Description
Questionnaire assessing self-reported insomnia symptoms, range 0-32, higher numbers indicate less symptoms of insomnia
Time Frame
10 weeks after randomisation
Secondary Outcome Measure Information:
Title
Change in motor performance from training to retest
Description
Behavioural motor consolidation assessment, assessed as accuracy (range 0-50, higher numbers indicate better accuracy of motor performance)
Time Frame
10 weeks after randomisation
Title
Patient Health Questionnaire
Description
Questionnaire assessing symptoms of depression, range 0-20, higher values indicate more depressive symptoms
Time Frame
10 weeks after randomisation
Title
Fatigue Severity Scale
Description
Questionnaire assessing fatigue, range 9-63, higher score indicates more severe fatigue
Time Frame
10 weeks after randomisation
Title
Actigraphy
Description
Wearable activity monitor used for assessing sleep disruption (Total Sleep Time, Wake After Sleep Onset, sleep fragmentation)
Time Frame
10 weeks after randomisation
Other Pre-specified Outcome Measures:
Title
Adherence of at home motor training
Description
Assessment of number of sessions performed, number of repetitions etc.
Time Frame
14 weeks following randomisation
Title
Upper limb ability
Description
Assessed with Action Research Arm Test, range 0-57, higher score indicates better upper limb ability
Time Frame
14 weeks following randomisation
Title
Upper limb function
Description
Assessed with Box and Blocks Test, scored as the number of blocks transferred in 60 seconds
Time Frame
14 weeks following randomisation
Title
Upper limb dexterity
Description
Assessed with Nine hole peg test, scored as the number of pegs placed in 30 seconds
Time Frame
14 weeks following randomisation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Willing and able to give informed consent for participation in the study
Aged 18 years or above.
Clinical diagnosis of stroke affecting the upper limb, with sufficient movement to perform the motor learning task
Discharged from inpatient care
Interest in accessing a programme with the aim of improving sleep quality
Reliable access to the internet
Exclusion Criteria:
Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis)
Diagnosed, untreated, sleep disorder (e.g. Sleep Apnea)
Uncontrolled seizures
Planned inpatient admission (e.g. for rehabilitation) in the next 4 months that would impact ability to engage with the Sleepio programme
Engagement in psychological therapy for insomnia in the past 12 months
Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Melanie K Fleming, Dr
Phone
01865 611 461
Email
melanie.fleming@ndcn.ox.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Barbara Robinson
Email
sleep-win@ndcn.ox.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Melanie K Fleming, Dr
Organizational Affiliation
University of Oxford
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Oxford
City
Oxford
ZIP/Postal Code
OX39DU
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Barbara Robinson
Email
sleep-win@ndcn.ox.ac.uk
First Name & Middle Initial & Last Name & Degree
Melanie Fleming
Email
melanie.fleming@ndcn.ox.ac.uk
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified data are available upon reasonable request
IPD Sharing Time Frame
Following publication of results
IPD Sharing Access Criteria
Available upon reasonable request
Learn more about this trial
Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
We'll reach out to this number within 24 hrs